These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1546516)

  • 21. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
    Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
    Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytological study of serous effusions with the aid of tumour markers.
    Ray K; Mittal S; Gupta H; Jain M
    J Indian Med Assoc; 1999 Jan; 97(1):11-2, 19. PubMed ID: 10549179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differential cytology of effusions using monoclonal antibodies].
    Lüttges J; Neumann K; Pflüger KH; Schmitz-Moormann P
    Pathologe; 1988 May; 9(3):137-42. PubMed ID: 2457213
    [No Abstract]   [Full Text] [Related]  

  • 24. The correlation of routine cytology with the contents of carcinoembryonic antigen and alpha-fetoprotein in pleural and peritoneal effusions.
    Breborowicz D; Majewski P; Simon I; Gladysz K; Breborowicz J
    Arch Geschwulstforsch; 1977; 47(3):231-5. PubMed ID: 71884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of immunocytochemistry in the study of malignant effusions.
    Mason MR; Bedrossian CW; Fahey CA
    Diagn Cytopathol; 1987 Sep; 3(3):215-21. PubMed ID: 3311665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
    Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
    Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic value of carcinoembryonic antigen (CEA) concentration in malignant pleural and ascitic fluids - in comparison with cytodiagnosis (author's transl)].
    Makino M; Matsui H; Kato S; Koshimizu M; Kimura M
    Rinsho Byori; 1981; 29(7):736-40. PubMed ID: 7328807
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
    Ko EC; Jhala NC; Shultz JJ; Chhieng DC
    Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of three tumor markers determined in pleural effusions.
    Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L
    Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
    Niwa Y; Shimokata K
    Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
    Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
    Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
    Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
    Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of epithelial antigens in diagnosis and staging of breast cancer].
    Artamonova EV; Tupitsyn NN; Kadagidze ZG; Letiagin VP; Ermilova VD; Ognerubov NA; Panichenko AV; Riazantseva SN
    Arkh Patol; 2002; 64(6):13-5. PubMed ID: 12534220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gallbladder cancer: immunohistochemical expression of CA-19-9, epithelial membrane antigen, dupan-2 and carcinoembryonic antigen].
    Roa I; Araya JC; Shiraisch T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X
    Rev Med Chil; 1992 Nov; 120(11):1218-26. PubMed ID: 1340939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [High Ca 125 serum level in benign ascites or pleural effusion].
    Mezger J; Häussinger KE; Wilmanns W; Lamerz R
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):463-5. PubMed ID: 3476336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of carcinoembryonic antigen assay of pleural & peritoneal effusions in malignancy.
    Gandhi AK; Nayar M; Bihari N; Chandra M
    Indian J Med Res; 1989 Feb; 90():22-6. PubMed ID: 2722212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4.
    Illingworth AL; Young JA; Johnson GD
    Cytopathology; 1994 Oct; 5(5):270-81. PubMed ID: 7819512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases.
    Loy TS; Diaz-Arias AA; Bickel JT
    Mod Pathol; 1990 May; 3(3):294-7. PubMed ID: 2194212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
    Wu GP; Zhang SS; Fang CQ; Liu SL; Wang EH
    Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.